2024-12-29-PitchBook-PitchBook年三季度新兴技术指标（英）_34页_4mb

报告摘要

Total Deal Value: ETI (angel, seed, early-stage) deals reached $4.7 billion in Q3 2024, slightly lower than Q2’s $11.8 billion but still above Q3 2023.
Deal Count: 175 deals completed, the lowest in the observed period, reflecting fewer but higher-value transactions.
Large Deals: Six deals crossed $100 million (revenue normalized to historical averages), while 18 deals exceeded $50 million (above historical averages).

AI & ML: Dominated with $2 billion across 42 deals, led by Safe Superintelligence ($1 billion), World Labs ($230 million), and Contextual.ai ($80 million).
Biotech: $472.5 million raised across 5 deals, with Metsera ($350 million) and IDRx ($120 million) as key players.
Fintech: $449 million across 18 deals, including Slope ($65 million) and Neo Asset Management ($47.9 million).
Web3 & DeFi: $373.8 million across 18 deals, driven by Story Protocol ($80 million) and IDPlanet ($80 million).
DevOps: Steady growth with $133.4 million across 4 deals, featuring Mechanical Orchard ($50 million) and Port ($35 million).

Median Deal Sizes: Angel/seed stage median rose to $7 million; early-stage rose to $26.1 million, showing resilience despite market correction.
Geographic Distribution: Non-US deals (29.1%) lagged behind historical averages, with Europe’s share declining significantly.
Sector Outperformance: ETI startups have higher exit and valuation rates compared to broader VC trends.

AI & ML and biotech remain top investment areas, with record-breaking deals in safe AI research and obesity treatments.
Q3 activity reflects a post-correction normalization after Q2’s outlier ($6 billion investment).
Venture firm rankings emphasize performance in exit rates, valuation growth, and follow-on success.

展开完整摘要